locanabio.comHealthcareFounded: 2016Funding to Date: $159MM
Locanabio develops a new class of genetic medicines that deliver RNA binding protein-based systems to correct the message of disease-causing RNA.
For more details on financing and valuation for LocanaBio, register or login.
View Enterprise Value for LocanaBio.
To read this article and more news on LocanaBio, register or login.